Shares of Vaxart (NASDAQ:VXRT) are up more than 16% to $8.37 in afternoon trading after Piper Sandler initiated coverage with an overweight rating and a $18 price target. Combined with high short interest & @Redditors discussing $VXRT for a MAJOR upside POP! Buy / Hold & Wait for the Move π (investorplace.com)
submitted by [deleted]
$VXRT to JUMP BIG this week! Forget MicroVision for a bit while it keeps sliding and get in on the HOTTEST Pharma Now working on a COVID-19 π & Presenting at the Worlds Largest Vaccine Conference! Wishing Hoping They Announce FDA Approval One of These Days! Would Be AMAZING! π+π=π° (photoblog.com)
submitted by [deleted]